• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

iScience . Distinct CD8+ T cell types associated with COVID-19 severity in unvaccinated HLA-A2+ patients

tetano

Editor, Senior Moderator
iScience


. 2026 Apr 24;29(6):115880.
doi: 10.1016/j.isci.2026.115880. eCollection 2026 Jun 19.
Distinct CD8[SUP]+[/SUP] T cell types associated with COVID-19 severity in unvaccinated HLA-A2[SUP]+[/SUP] patients

Kazuya Masuda[SUP] 1 2 [/SUP], Sho Iketani[SUP] 1 2 3 [/SUP], Lihong Liu[SUP] 1 2 [/SUP], Jing Huang[SUP] 1 2 [/SUP], Yujie Qiao[SUP] 1 2 [/SUP], Jayesh Shah[SUP] 2 [/SUP], Meredith L McNairy[SUP] 2 [/SUP], Christine Groso[SUP] 1 2 [/SUP], Christopher L Ricupero[SUP] 4 [/SUP], Lucas F Loffredo[SUP] 3 [/SUP], Qian Wang[SUP] 1 2 [/SUP], Lawrence Purpura[SUP] 2 [/SUP], Jordana Grazziela Alves Coelho-Dos-Reis[SUP] 5 [/SUP], Zizhang Sheng[SUP] 1 2 [/SUP], Michael T Yin[SUP] 1 2 [/SUP], Moriya Tsuji[SUP] 1 2 [/SUP]


Affiliations
Abstract

Despite emerging studies about coronavirus disease 2019 (COVID-19)-associated adaptive immune responses, CD8[SUP]+[/SUP] T cell immunity in the context of HLA restriction, particularly in unvaccinated patients, remains largely uncharacterized. Here, we show that in HLA-A2-positive patients with COVID-19, cell-mediated immune responses are crucial in determining disease severity, irrespective of humoral immune responses. We observe robust cell-mediated immune responses against our selected, highly conserved 9-mer severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epitopes in mild patients but poor responsiveness in severe patients. Single-cell analyses of HLA-A2-restricted CD8[SUP]+[/SUP] T cells against those epitopes reveal distinct cellular profiles between mild and severe COVID-19. In mild COVID-19, effector KLRB1 [SUP]+[/SUP] innate-like cells, IFNG [SUP]hi[/SUP] ID3 [SUP]hi[/SUP] memory cells, and IL7R [SUP]+[/SUP] proliferative stem cell-like memory cells are preferentially detected. By contrast, severe cases are featured by dysfunctional T cell types, particularly early terminated and terminally differentiated subtypes. Thus, our findings suggest that contrasting HLA-A2-restricted SARS-CoV-2 epitope-specific CD8[SUP]+[/SUP] T cell profiles reflect the magnitude of cellular immune responses, potentially affecting disease severity.

Keywords: Bioinformatics; Immunology.

 
Back
Top